NRx Pharmaceuticals PE Ratio 2018-2025 | NRXP

Current and historical p/e ratio for NRx Pharmaceuticals (NRXP) from 2018 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NRx Pharmaceuticals PE ratio as of January 09, 2026 is 0.00.
NRx Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-01-09 2.22 0.00
2025-09-30 3.30 $-2.35 0.00
2025-06-30 3.26 $-2.24 0.00
2025-03-31 2.05 $-2.01 0.00
2024-12-31 2.20 $-2.41 0.00
2024-09-30 1.69 $-2.14 0.00
2024-06-30 2.44 $-2.69 0.00
2024-03-31 4.72 $-3.14 0.00
2023-12-31 4.60 $-4.00 0.00
2023-09-30 2.60 $-5.10 0.00
2023-06-30 4.84 $-5.80 0.00
2023-03-31 6.59 $-5.70 0.00
2022-12-31 11.10 $-6.20 0.00
2022-09-30 7.40 $-5.50 0.00
2022-06-30 6.00 $-8.10 0.00
2022-03-31 24.50 $-72.10 0.00
2021-12-31 47.80 $-73.30 0.00
2021-09-30 92.70 $-72.40 0.00
2021-06-30 116.20 $-68.40 0.00
2021-03-31 354.20 $-3.30 0.00
2020-12-31 244.00 0 0.00
2020-09-30 107.30 0 0.00
2020-06-30 105.00 0 0.00
2020-03-31 107.70 0 0.00
2019-12-31 106.00 0 0.00
2019-09-30 105.80 0 0.00
2019-06-30 105.30 0 0.00
2019-03-31 103.30 0 0.00
2018-12-31 102.00 0 0.00
2018-09-30 100.10 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.066B $0.000B
NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.187B 33.88
Zoetis (ZTS) United States $56.043B 20.06
Takeda Pharmaceutical (TAK) Japan $51.898B 10.59
Daiichi Sankyo, - (DSNKY) Japan $43.551B 21.69
BeOne Medicines - (ONC) Switzerland $37.054B 196.45
Sandoz Group AG (SDZNY) Switzerland $33.348B 0.00
United Therapeutics (UTHR) United States $20.806B 18.31
Merck (MKKGY) Germany $19.348B 11.93
Shionogi (SGIOY) Japan $15.738B 14.45
Summit Therapeutics (SMMT) United States $15.176B 0.00
Neurocrine Biosciences (NBIX) United States $13.539B 32.49
Ionis Pharmaceuticals (IONS) United States $13.007B 0.00
IPSEN (IPSEY) France $12.338B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.675B 0.00
Orion OYJ (ORINY) Finland $11.045B 31.56
Eisai (ESAIY) $8.854B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.576B 20.00
Grifols, S.A (GRFS) Spain $6.442B 0.00
Stevanato Group S.p.A (STVN) Italy $6.378B 35.69
Crinetics Pharmaceuticals (CRNX) United States $5.053B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.613B 0.00
Indivior (INDV) United States $4.431B 18.08
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.074B 19.34
Corcept Therapeutics (CORT) United States $3.945B 42.61
NewAmsterdam Pharma (NAMS) Netherlands $3.897B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.014B 0.00
Hypermarcas (HYPMY) Brazil $2.914B 20.00
Catalyst Pharmaceuticals (CPRX) United States $2.793B 8.91
Dyne Therapeutics (DYN) United States $2.538B 0.00
Ocular Therapeutix (OCUL) United States $2.399B 0.00
Soleno Therapeutics (SLNO) United States $2.310B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.997B 23.67
Guardian Pharmacy Services (GRDN) United States $1.920B 36.98
Ardelyx (ARDX) United States $1.881B 0.00
Harrow (HROW) United States $1.733B 106.32
BioCryst Pharmaceuticals (BCRX) United States $1.559B 92.50
Enliven Therapeutics (ELVN) United States $1.543B 0.00
Collegium Pharmaceutical (COLL) United States $1.440B 7.13
Relay Therapeutics (RLAY) United States $1.385B 0.00
Oruka Therapeutics (ORKA) United States $1.349B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.341B 0.00
Xeris Biopharma Holdings (XERS) United States $1.316B 0.00
Evotec AG (EVO) Germany $1.300B 0.00
ARS Pharmaceuticals (SPRY) United States $1.291B 0.00
Savara (SVRA) United States $1.182B 0.00
Cronos Group (CRON) Canada $1.025B 0.00
Xencor (XNCR) United States $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.965B 40.51
Esperion Therapeutics (ESPR) United States $0.928B 0.00
KalVista Pharmaceuticals (KALV) United States $0.849B 0.00
Nektar Therapeutics (NKTR) United States $0.808B 0.00
Lexeo Therapeutics (LXEO) United States $0.769B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.741B 6.62
ProKidney (PROK) United States $0.704B 0.00
Bioventus (BVS) United States $0.665B 13.61
Ironwood Pharmaceuticals (IRWD) United States $0.660B 15.61
Organogenesis (ORGO) United States $0.534B 0.00
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Elite Pharmaceuticals (ELTP) United States $0.521B 0.00
Zevra Therapeutics (ZVRA) United States $0.478B 0.00
Aquestive Therapeutics (AQST) United States $0.477B 0.00
Siga Technologies (SIGA) United States $0.473B 6.48
4D Molecular Therapeutics (FDMT) United States $0.429B 0.00
Altimmune (ALT) United States $0.419B 0.00
Akebia Therapeutics (AKBA) United States $0.403B 0.00
Nature's Sunshine Products (NATR) United States $0.380B 22.64
USANA Health Sciences (USNA) United States $0.363B 10.13
Relmada Therapeutics (RLMD) United States $0.316B 0.00
Avalo Therapeutics (AVTX) United States $0.314B 0.00
Profound Medical (PROF) Canada $0.306B 0.00
Protara Therapeutics (TARA) United States $0.297B 0.00
Achieve Life Sciences (ACHV) Canada $0.296B 0.00
Aclaris Therapeutics (ACRS) United States $0.286B 0.00
Larimar Therapeutics (LRMR) United States $0.276B 0.00
OmniAb (OABI) United States $0.275B 0.00
Fractyl Health (GUTS) United States $0.274B 0.00
Silence Therapeutics (SLN) United Kingdom $0.261B 0.00
Heron Therapeutics (HRTX) United States $0.255B 0.00
Aldeyra Therapeutics (ALDX) United States $0.247B 0.00
Enlivex Therapeutics (ENLV) Israel $0.214B 0.00
MediWound (MDWD) Israel $0.207B 0.00
Galectin Therapeutics (GALT) United States $0.203B 0.00
Journey Medical (DERM) United States $0.197B 0.00
Minerva Neurosciences (NERV) United States $0.193B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.188B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Century Therapeutics (IPSC) United States $0.170B 0.00
Prelude Therapeutics (PRLD) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
AleAnna (ANNA) United States $0.160B 0.00
Karyopharm Therapeutics (KPTI) United States $0.159B 0.00
Surrozen (SRZN) United States $0.158B 0.00
Context Therapeutics (CNTX) United States $0.148B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Incannex Healthcare (IXHL) Australia $0.137B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.127B 0.00
Pyxis Oncology (PYXS) United States $0.110B 0.00
Avita Medical (RCEL) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.099B 0.00
Vivani Medical (VANI) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.094B 39.88
Korro Bio (KRRO) United States $0.089B 0.00
Gain Therapeutics (GANX) United States $0.089B 0.00
Plus Therapeutics (PSTV) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 61.88
PolyPid (PYPD) Israel $0.074B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Metagenomi (MGX) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Arch Biopartners (ACHFF) Canada $0.064B 0.00
PMV Pharmaceuticals (PMVP) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Acrivon Therapeutics (ACRV) United States $0.055B 0.00
Lite Strategy (LITS) United States $0.054B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Talphera (TLPH) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
FibroGen (KYNB) United States $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Wellgistics Health (WGRX) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.023B 0.00
Inotiv (NOTV) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Liminatus Pharma (LIMN) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Vyome Holdings (HIND) United States $0.018B 0.00
China SXT Pharmaceuticals (SXTC) China $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tempest Therapeutics (TPST) United States $0.014B 0.00
CASI Pharmaceuticals (CASI) China $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.01
Curanex Pharmaceuticals Inc (CURX) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Salarius Pharmaceuticals (DCOY) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00